ASPO Logo

Welcome to ASPO Abstract Submission!

50th Annual Meeting

April 12-14, 2026

Hilton Denver City Center

For Submission of oral presentations and posters at ASPO’s 50th Annual Meeting.

SUBMISSION DEADLINE: Friday, October 17, 2025 at 11:59 pm PST.

ASPO encourages members and non-members to submit an abstract for consideration as either an oral or poster presentation. All abstracts must be data-driven. Abstracts for Oral Presentations will be selected based on their scientific review by the Program Committee and their alignment with the major sessions and topics of the meeting as outlined below. Please review these sessions and topics and think about how your abstract aligns with each.

2026 Annual Meeting: Main Symposia

  • GLP-1 Agonists, Cancer Prevention and Survivorship
  • Application of AI Tools to Enhance Cancer Control
  • Multi-Cancer Detection (MCD) Tests in the Context of Current Cancer Screening
  • Rising Cancer Incidence in Young Adults: Risk Factors and Screening Strategies

Looking Back, Thinking Forward Sessions

We will first “look back” at the history of a topic area with a senior investigator in the field and then “think forward” with five-minute flash talks from junior investigators and/or trainees. Flash talks will be selected from submitted abstracts. If you’d like to be considered, please select the appropriate session below under the preferred format.

Looking Back, Thinking Forward Session Topics:

  • HPV and Cancer Prevention
  • Extreme Weather and Health, Toxic Environment Exposures
  • Molecular Epidemiology: From Bench to Community
  • Turning Evidence into Impact

Call for Abstracts

Abstracts are sought across ASPO’s Cancer Prevention & Control Continuum, with particular interest in those addressing the following topic areas that align with the SIGs:

  1. Cancer Health Disparities
  2. Behavioral Science & Health Communication
  3. Early Detection & Risk Prediction of Cancer
  4. Global Cancer Research
  5. Lifestyle & Preventive Interventions
  6. Molecular Epidemiology & The Environment
  7. Cancer Survivorship

New Topics for 2026:

  1. Foundational Science & Policy
  2. Community & Science

ASPO abstract review process is:

  • The ASPO Program Committee, along with volunteer reviewers, will review all abstracts and rank them based on a merit scoring system.
  • The highest scoring abstracts will be selected for oral presentation.

Please adhere to the following instructions to receive full consideration:

  1. List title of abstract in Title box
  2. List authors (last name first initial) in Author box
  3. Select relevant topic area(s). You are welcome to select up to two areas.
  4. Indicate preference for oral presentation or poster and if the corresponding author is a trainee (pre-doc, post-doc).
  5. Provide a structured abstract (up to 2300 characters including spaces) with these sections:
    1. Purpose of the study (one sentence if possible);
    2. Methods;
    3. Results (adequate to support conclusion);
    4. Conclusions (Do not use phrases such as “The results will be discussed”).
    5. No illustrations are permitted in this section.
  6. List 2-3 Key words.

It is NOT possible to save partially completed abstracts. Therefore, we recommend that the complete document be prepared and finalized, then cut and pasted into the appropriate fields. Please note that it will not be possible to edit an abstract after it has been submitted.

**IMPORTANT** If you do not receive a confirmation email (check your spam box also) after submitting your abstract with the text exactly as you submitted, please contact Julie Graef at [email protected].

If your abstract is accepted, the corresponding author (or designated co-author) must register and attend the ASPO conference; otherwise, the abstract will be withdrawn.

General Information

Enter the title of your abstract. Please use Title Case.

You may enter up to 15 authors here. Enter in the format of Last Name followed by first and middle initial (i.e. Smith AB).

Presentation

Please consider my abstract for: (check all that apply)







Abstract Content

Are you a pre-doc or post-doc trainee?

Pre-Doc
Post-Doc Trainee
Not a Trainee

Enter the text of your abstract in the box. You can use up to 2300 characters, including spaces.

Contact Person

Enter details for corresponding author.

Mailing Address

Travel Awards

Would you like to be considered for the Electra Paskett Annual Scholarship Award?

The Electra Paskett Annual Scholarship Award is given for the top ranking abstract submitted by either a pre or postdoctoral fellow. It will cover registration and up to $1,000 in travel-related expenses for ASPO 2026. This award is named in honor of ASPO's past president for her outstanding commitment to mentorship and training and in recognition of her visionary leadership.

Would you like to be considered for the ASPO Scholarship Awards for Pre- and Post-doc trainees?

ASPO Scholarship Awards are given to top-ranking abstracts submitted by pre- or post-doctoral trainees. They cover registration and up to $1,000 in travel-related expenses for ASPO 2026.

Would you like to be considered for the ASPO Minority Travel Award for a Top Ranked Abstract?

The ASPO Minority Travel Award is given for one top ranking abstract submitted by full-time graduate or medical students, residents, clinical or postdoctoral fellows, or junior faculty members from groups considered to be underrepresented in cancer research (African-Americans, Hispanic-Americans, Native-Americans, Native Pacific Islanders/Hawaiians, and Alaska Natives), as defined by the NCI. Each award will cover registration and $1,000 of travel related expenses to the ASPO conference.

Agreement

Accepted abstracts will be compiled into the Book of Abstracts and Conference Proceedings for wide distribution. Abstracts that do not follow the above format may not be included. By submitting an abstract, you authorize its inclusion in these publications with minor edits as needed.

Please note that once you click on the button below, your abstract will be submitted and no further changes can be made. We appreciate your interest in this conference.